FOI services, Inc.


EIRs Full Text!

Click here to search inspection documents FULL TEXT!

Searching is free.
No subscription.
No obligation.

Why Full-Text?

You can already search the descriptions of all of FOI's records, and now, you can search the full text of EIRs, 483s, FDA/Industry correspondence and other inspection-related content for revealing and hard to find information:

• Preparing for your own inspections
• Designing realistic mock audits
• Researching competitors
• Learning about suppliers, clinical investigators, potential acquisitions
• And much more!

  

  

Enter your keyword(s) to search the
descriptions of unpublished FDA FOIA records:

Popular searches include: drug trade or generic names; FDA investigator names, company names, device names or 510(k) numbers & more - see Search Hints for more ideas!

Your results may include Establishment Inspection Reports; Investigator Diaries; 483s; correspondence; 510(k)s (not just summaries!); meeting records;
drug, device & biologic original & supplemental reviews & more.


The Freedom of Information Act (FOIA) requires U.S. agencies to disclose many of their records. FDA's FOIA records usually aren't on the agency website; they're files from the desk drawers of reviewers, investigators, and other officials - and FOI Services has collected over 100,000 of these documents. Please note that under the Freedom of Information Act, the FDA is required to remove certain information from documents prior to releasing them. Some types of documents, such as 510(k)s and PMAs, are more heavily redacted than others. Most redactions used on these documents fall under the (b)(4) and (b)(5) exemptions of the Freedom of Information Act. Contact us at infoFOI@foiservices.com for more information.


Find a Document You Need?
Add it to your cart and download it immediately.


Want Some Advice?
Contact us...our information specialists can explain document
content, help you search, and answer other questions.


Can't Find Something?
Call us at +1-301-975-9400 to place a custom request.

  
Events!

FOIA & COVID-19: FDA's Freedom of Information Office has completed the transition to full-time teleworking. Requests are being accepted; response times, for the most part, have not significantly changed, though offices active in working with COVID-19 information are stretched thin. FOI Services is operating normally. Please email us at infoFOI@foiservices.com or call +1-301-975-9400 if you have questions.


NOW ONLINE: What are your colleagues & competitors reading? See a list of the unpublished documents we've just received on our New Documents page.



 Free!

Document of the Week...

US Biomedical Research: Undue Foreign Influence

This April 2021 testimony before the US Senate was prepared and presented by the Office of Inspector General (OIG) of the Department of Health and Human Services to present the OIG's efforts to protect taxpayer-funded medical research and insure research integrity. The testimony summarizes, primarily, how OIG reviews allegations of the failure of grantee principal investigators to disclose foreign government affiliations, and specifically describes its strategy of the prevention of, and enforcement action against, grant fraud.

Featured until February 1, 2022. Click here to download.